The resolution designates the third full week of May each year as Clinical Trials Awareness Week and May 20 as Clinical Trials Volunteers Appreciation Day in New Jersey. This initiative aims to promote public awareness and understanding of the critical role that clinical trials play in modern medicine, as well as to express gratitude to the volunteers who participate in these trials. The resolution highlights the historical significance of clinical trials, referencing the first randomized trial conducted by British naval surgeon James Lind in 1747, which led to the eradication of scurvy in the British Navy. It emphasizes the importance of clinical trials in advancing medical research, particularly in the development of new treatments for diseases such as cancer and COVID-19.

The resolution also notes the substantial contributions of New Jersey to clinical research, with numerous trials conducted by institutions like the Rutgers Cancer Institute and Cooper Research Institute. It underscores the state's position as a leader in pharmaceutical development, with a significant number of new cancer drugs in progress and a considerable economic impact from clinical trials. By establishing these observances, the resolution seeks to enhance public recognition of the value of clinical trials and the selfless contributions of volunteers, ultimately fostering a greater understanding of their benefits to society.